Literature DB >> 21562250

Longitudinal change in CSF biomarkers in a presymptomatic carrier of an APP mutation.

J M Ringman1, K Taylor, E Teng, G Coppola, K Gylys.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21562250      PMCID： PMC3111239          DOI： 10.1212/WNL.0b013e31821f4488

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  7 in total

1.  Serial MRI and CSF biomarkers in normal aging, MCI, and AD.

Authors:  P Vemuri; H J Wiste; S D Weigand; D S Knopman; J Q Trojanowski; L M Shaw; M A Bernstein; P S Aisen; M Weiner; R C Petersen; C R Jack
Journal:  Neurology       Date:  2010-07-13       Impact factor: 9.910

2.  Correlation of longitudinal cerebrospinal fluid biomarkers with cognitive decline in healthy older adults.

Authors:  Erik Stomrud; Oskar Hansson; Henrik Zetterberg; Kaj Blennow; Lennart Minthon; Elisabet Londos
Journal:  Arch Neurol       Date:  2010-02

3.  Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice.

Authors:  N Andreasen; L Minthon; P Davidsson; E Vanmechelen; H Vanderstichele; B Winblad; K Blennow
Journal:  Arch Neurol       Date:  2001-03

4.  CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

Authors:  Niklas Mattsson; Henrik Zetterberg; Oskar Hansson; Niels Andreasen; Lucilla Parnetti; Michael Jonsson; Sanna-Kaisa Herukka; Wiesje M van der Flier; Marinus A Blankenstein; Michael Ewers; Kenneth Rich; Elmar Kaiser; Marcel Verbeek; Magda Tsolaki; Ezra Mulugeta; Erik Rosén; Dag Aarsland; Pieter Jelle Visser; Johannes Schröder; Jan Marcusson; Mony de Leon; Harald Hampel; Philip Scheltens; Tuula Pirttilä; Anders Wallin; Maria Eriksdotter Jönhagen; Lennart Minthon; Bengt Winblad; Kaj Blennow
Journal:  JAMA       Date:  2009-07-22       Impact factor: 56.272

5.  Biochemical markers in persons with preclinical familial Alzheimer disease.

Authors:  J M Ringman; S G Younkin; D Pratico; W Seltzer; G M Cole; D H Geschwind; Y Rodriguez-Agudelo; B Schaffer; J Fein; S Sokolow; E R Rosario; K H Gylys; A Varpetian; L D Medina; J L Cummings
Journal:  Neurology       Date:  2008-05-28       Impact factor: 9.910

6.  Clinical comparison of Alzheimer's disease in pedigrees with the codon 717 Val-->Ile mutation in the amyloid precursor protein gene.

Authors:  M Mullan; S Tsuji; T Miki; T Katsuya; S Naruse; K Kaneko; T Shimizu; T Kojima; I Nakano; T Ogihara
Journal:  Neurobiol Aging       Date:  1993 Sep-Oct       Impact factor: 4.673

7.  Intra-individual stability of CSF biomarkers for Alzheimer's disease over two years.

Authors:  Henrik Zetterberg; Mona Pedersen; Karin Lind; Maria Svensson; Sindre Rolstad; Carl Eckerström; Steinar Syversen; Ulla-Britt Mattsson; Christina Ysander; Niklas Mattsson; Arto Nordlund; Hugo Vanderstichele; Eugeen Vanmechelen; Michael Jonsson; Ake Edman; Kaj Blennow; Anders Wallin
Journal:  J Alzheimers Dis       Date:  2007-11       Impact factor: 4.472
  7 in total
  9 in total

1.  Memory performance and fMRI signal in presymptomatic familial Alzheimer's disease.

Authors:  Meredith N Braskie; Luis D Medina; Yaneth Rodriguez-Agudelo; Daniel H Geschwind; Miguel Angel Macias-Islas; Paul M Thompson; Jeffrey L Cummings; Susan Y Bookheimer; John M Ringman
Journal:  Hum Brain Mapp       Date:  2012-07-17       Impact factor: 5.038

2.  Associations between biomarkers and age in the presenilin 1 E280A autosomal dominant Alzheimer disease kindred: a cross-sectional study.

Authors:  Adam S Fleisher; Kewei Chen; Yakeel T Quiroz; Laura J Jakimovich; Madelyn Gutierrez Gomez; Carolyn M Langois; Jessica B S Langbaum; Auttawut Roontiva; Pradeep Thiyyagura; Wendy Lee; Napatkamon Ayutyanont; Liliana Lopez; Sonia Moreno; Claudia Muñoz; Victoria Tirado; Natalia Acosta-Baena; Anne M Fagan; Margarita Giraldo; Gloria Garcia; Matthew J Huentelman; Pierre N Tariot; Francisco Lopera; Eric M Reiman
Journal:  JAMA Neurol       Date:  2015-03       Impact factor: 18.302

3.  Cerebrospinal fluid biomarkers and proximity to diagnosis in preclinical familial Alzheimer's disease.

Authors:  John M Ringman; Giovanni Coppola; David Elashoff; Yaneth Rodriguez-Agudelo; Luis D Medina; Karen Gylys; Jeffrey L Cummings; Greg M Cole
Journal:  Dement Geriatr Cogn Disord       Date:  2012-02-13       Impact factor: 2.959

Review 4.  New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs.

Authors:  Salvatore Salomone; Filippo Caraci; Gian Marco Leggio; Julia Fedotova; Filippo Drago
Journal:  Br J Clin Pharmacol       Date:  2012-04       Impact factor: 4.335

5.  Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease.

Authors:  Anne M Fagan; Chengjie Xiong; Mateusz S Jasielec; Randall J Bateman; Alison M Goate; Tammie L S Benzinger; Bernardino Ghetti; Ralph N Martins; Colin L Masters; Richard Mayeux; John M Ringman; Martin N Rossor; Stephen Salloway; Peter R Schofield; Reisa A Sperling; Daniel Marcus; Nigel J Cairns; Virginia D Buckles; Jack H Ladenson; John C Morris; David M Holtzman
Journal:  Sci Transl Med       Date:  2014-03-05       Impact factor: 17.956

6.  Defining and describing the pre-dementia stages of familial Alzheimer's disease.

Authors:  Natalie S Ryan; Martin N Rossor
Journal:  Alzheimers Res Ther       Date:  2011-09-27       Impact factor: 6.982

Review 7.  Autosomal Dominant Alzheimer Disease: A Unique Resource to Study CSF Biomarker Changes in Preclinical AD.

Authors:  Suzanne Elizabeth Schindler; Anne M Fagan
Journal:  Front Neurol       Date:  2015-06-29       Impact factor: 4.003

8.  Conformation-dependent oligomers in cerebrospinal fluid of presymptomatic familial Alzheimer's disease mutation carriers.

Authors:  John M Ringman; Jennifer L Tomic; Giovanni Coppola; David Elashoff; Karen H Gylys; Charles G Glabe
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2012-12-15

9.  CSF protein biomarkers predicting longitudinal reduction of CSF β-amyloid42 in cognitively healthy elders.

Authors:  N Mattsson; P Insel; R Nosheny; H Zetterberg; J Q Trojanowski; L M Shaw; D Tosun; M Weiner
Journal:  Transl Psychiatry       Date:  2013-08-20       Impact factor: 6.222
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.